Skip to content
Steven Locke, MD Integrative Psychiatry · Telehealth
    • About Dr. Locke
    • About My Practice
    • Licenses
    • Curriculum Vitae (CV)
    • Patient Reviews
  • Services
    • Consultation
    • Psychiatric Evaluation
    • Diagnostic Evaluation
    • Medication Management (Psychopharmacology)
    • Talk Therapy (Psychotherapy)
    • Life Coaching
    • Wellness Coaching
    • Stress Management
    • Teletherapy
    • Forms
    • Downloads
    • Videos
    • How to Find a Psychiatrist
    • How to Find a Therapist
  • HPPD
  • Blog
  • Contact Us
Schedule a Consultation
Category

Psychedelics

All Posts ADHD 5 Anxiety 23 Coronavirus 12 Depression 21 HPPD 20 Loneliness 1 Medication 16 Mental Health 10 Psychedelics 11 Relationships 4 Self-care 41 Sleep 13 Student Health 8 Therapy 10 Visual Snow Syndrome 3
Psilocybin: What Patients Should Know
Depression

Psilocybin: What Patients Should Know

October 20, 2026

Psilocybin, the active ingredient in "magic mushrooms," is in the news a lot. Here is what it is, how it…

Continue reading → Psilocybin: What Patients Should Know
Psychedelics Are Moving Toward Approval. We Need to Talk About the Patients Who Don’t Come All the Way Back.
Psychedelics

Psychedelics Are Moving Toward Approval. We Need to Talk About the Patients Who Don’t Come All the Way Back.

July 30, 2026

2026 may be remembered as the year psychedelic medicine crossed into the mainstream. A federal push to accelerate treatments for…

Continue reading → Psychedelics Are Moving Toward Approval. We Need to Talk About the Patients Who Don’t Come All the Way Back.
Dr. Steven Locke to Speak on Psychedelic Safety and Risk at Psychedelic Science 2025
HPPD

Dr. Steven Locke to Speak on Psychedelic Safety and Risk at Psychedelic Science 2025

June 14, 2025

Top HPPD Psychiatrists in the USA - Dr. Steven Locke, MD Speaks at Psychedelic Science 2025

Continue reading → Dr. Steven Locke to Speak on Psychedelic Safety and Risk at Psychedelic Science 2025
Decriminalization of Magic Mushrooms: Implications for Behavioral Health and Psychiatry
Psychedelics

Decriminalization of Magic Mushrooms: Implications for Behavioral Health and Psychiatry

December 12, 2024

The recent movement toward the decriminalization of magic mushrooms (psilocybin) reflects a growing recognition of their potential therapeutic benefits, particularly…

Continue reading → Decriminalization of Magic Mushrooms: Implications for Behavioral Health and Psychiatry
A New Hope: Psychedelic-Assisted Therapy in the Treatment of PTSD and Substance Use Disorders
Therapy

A New Hope: Psychedelic-Assisted Therapy in the Treatment of PTSD and Substance Use Disorders

September 17, 2024

The field of mental health is witnessing a transformative shift with the reemergence of psychedelic-assisted therapy as a powerful tool…

Continue reading → A New Hope: Psychedelic-Assisted Therapy in the Treatment of PTSD and Substance Use Disorders
Psychedelics and the Law: Understanding the Global Regulatory Landscape
Psychedelics

Psychedelics and the Law: Understanding the Global Regulatory Landscape

September 13, 2024

The resurgence of interest in psychedelic substances for therapeutic purposes has sparked significant debate and led to various legal developments…

Continue reading → Psychedelics and the Law: Understanding the Global Regulatory Landscape
Navigating the Ethical Landscape of Psychedelic Therapy: Ensuring Safe and Responsible Use
Psychedelics

Navigating the Ethical Landscape of Psychedelic Therapy: Ensuring Safe and Responsible Use

September 9, 2024

The resurgence of interest in psychedelic therapy, driven by promising research into its potential benefits for mental health, has sparked…

Continue reading → Navigating the Ethical Landscape of Psychedelic Therapy: Ensuring Safe and Responsible Use
Psychedelic Psychiatry: The Promise of Magic Mushrooms in Mental Health Treatment
Psychedelics

Psychedelic Psychiatry: The Promise of Magic Mushrooms in Mental Health Treatment

July 15, 2024

In recent years, a once-taboo subject has re-emerged at the forefront of psychiatric research and treatment: psychedelic substances. Among these,…

Continue reading → Psychedelic Psychiatry: The Promise of Magic Mushrooms in Mental Health Treatment
Understanding HPPD: A Rare but Serious Risk of Psychedelic Use
HPPD

Understanding HPPD: A Rare but Serious Risk of Psychedelic Use

May 31, 2024

Hallucinogen Persisting Perception Disorder (HPPD) stands as a stark reminder of the potential risks associated with psychedelic substances. Despite its…

Continue reading → Understanding HPPD: A Rare but Serious Risk of Psychedelic Use
Telehealth and ketamine
Medication

Telehealth and ketamine

March 20, 2023

Telehealth has expanded exponentially since the pandemic increased demand for remote health services. The expansion of this service made prescription…

Continue reading → Telehealth and ketamine

Posts pagination

1 2 Older
Steven Locke, MD

Integrative psychiatry and behavioral medicine, delivered by secure telehealth to patients in six states.

Explore

About Dr​. LockeServicesHPPD & Visual SnowLicensesPatient ReviewsBlog

Connect

508-343-0001 · New patients617-485-1168 · OfficePre-onboarding formLinkedIn
© 2026 Steven Locke, MD. All rights reserved. Confidentiality and privacy are essential to psychiatric care; all communications are handled under a HIPAA Notice of Privacy Practices. Any images representing patients are illustrative and not actual patients. Powered by QBIT BRAINS